(Q46393465)

21 December 2017

title

Identification of EGFR kinase domain mutations among lung cancer patients in China: implication for targeted cancer therapy (English)

1 reference

21 December 2017

People's Republic of China

main subject

0 references

1 reference

Bao Ming Qin

1

1 reference

21 December 2017

Xiao Chen

series ordinal

2

1 reference

21 December 2017

Jing De Zhu

series ordinal

3

1 reference

21 December 2017

Duan Qing Pei

series ordinal

4

1 reference

21 December 2017

publication date

1 March 2005

1 reference

21 December 2017

published in

Cell Research

1 reference

21 December 2017

volume

15

1 reference

21 December 2017

issue

3

1 reference

21 December 2017

page(s)

212-217

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.cr.7290289

exact match

0 references

cites work

Cancer. A bull's eye for targeted lung cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290289

Chasing mutations in the epidermal growth factor in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290289

Gefitinib: current status in the treatment of non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290289

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290289

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290289

High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290289

Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290289

Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290289

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290289

EGFR gene mutations: a call for global x global views of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290289

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.CR.7290289

1 reference

21 December 2017

PubMed ID

15780185

1 reference

21 December 2017